Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus–infected pregnant women
- 1 January 2001
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 184 (2) , 153-158
- https://doi.org/10.1067/mob.2001.108344
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analoguesThe Lancet, 1999
- Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected WomenJAMA, 1999
- Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their OffspringThe Journal of Infectious Diseases, 1998
- Initial Multicenter Experience With DoubleNucleoside Therapy for Human ImmunodeficiencyVirus Infection During PregnancyInfectious Diseases in Obstetrics and Gynecology, 1998
- Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in FranceThe Journal of Pediatrics, 1997
- LamivudineDrugs, 1997
- Antiretroviral therapy for pregnant womenAmerican Journal of Obstetrics and Gynecology, 1997
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serumJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidineBiochemical Pharmacology, 1992